End of the Double-Blind Randomized Control Trial?

Pleasance et al.  Nature 463, 184-190 (14 January 2010).

The short answer is probably not – the randomized control trial is safe for now.  The longer answer when it comes to exploring molecular targets in oncology we may need to rethink the double-blind randomized control trial. Since current methods Continue reading End of the Double-Blind Randomized Control Trial?

Oncology Informatics Provides Decision Support Based on Gene Mutations

mycancergenome.org

Oncology Informatics Provides Decision Support Based on Gene Mutations Below is a video introduction to a publicly available project, MyCancerGenome.org, that integrates physician decision support, treatment information, published evidence, and current clinical trials. This is a great example of the Continue reading Oncology Informatics Provides Decision Support Based on Gene Mutations